Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanli Xing

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Basic & Clinical Pharmacology & Toxicology|November 17, 2009
Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in ratsJianxiong Yang, Guanbo Zhang, Jingwei Tian, et al.
Frontiers in Immunology|September 11, 2023
Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancerYangyang Ma, Yanli Xing, Hongmei Li, et al.
European Journal of Medicinal Chemistry|April 5, 2016
Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluationYu Song, Xiaoqian Xue, Xishan Wu, et al.
European Journal of Pharmacology|September 25, 2010
Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathwaysChunmei Li, Jingwei Tian, Guisheng Li, et al.
Journal of Medicinal Chemistry|January 6, 2016
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological EvaluationXiaoqian Xue, Yan Zhang, Zhaoxuan Liu, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|October 10, 2018
[Analysis of mutations of 4 common genes among 216 patients with non-syndromic hearing impairment]Can Li, Dan Lu, Xiaoping Chen, et al.
Journal of Medicinal Chemistry|June 14, 2021
Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse AgonistXishan Wu, Hui Shen, Yan Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Daraxonrasib (RMC-6236) is an effective targeted therapy for <i>RAS</i> -mutant neuroblastomaRonald D Hill, Krista M Dalton, Richard Kurupi, et al.
BMC Public Health|September 5, 2018
Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional studyShishen Wang, Yuhui Tao, Yuchun Tao, et al.
Research Square|June 17, 2024
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial SarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Basic & Clinical Pharmacology & Toxicology|November 17, 2009
Cardioprotective effect of SMND-309, a novel derivate of salvianolic acid B on acute myocardial infarction in ratsJianxiong Yang, Guanbo Zhang, Jingwei Tian, et al.
Frontiers in Immunology|September 11, 2023
Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancerYangyang Ma, Yanli Xing, Hongmei Li, et al.
European Journal of Medicinal Chemistry|April 5, 2016
Identification of N-phenyl-2-(N-phenylphenylsulfonamido)acetamides as new RORγ inverse agonists: Virtual screening, structure-based optimization, and biological evaluationYu Song, Xiaoqian Xue, Xishan Wu, et al.
European Journal of Pharmacology|September 25, 2010
Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathwaysChunmei Li, Jingwei Tian, Guisheng Li, et al.
Journal of Medicinal Chemistry|January 6, 2016
Discovery of Benzo[cd]indol-2(1H)-ones as Potent and Specific BET Bromodomain Inhibitors: Structure-Based Virtual Screening, Optimization, and Biological EvaluationXiaoqian Xue, Yan Zhang, Zhaoxuan Liu, et al.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics|October 10, 2018
[Analysis of mutations of 4 common genes among 216 patients with non-syndromic hearing impairment]Can Li, Dan Lu, Xiaoping Chen, et al.
Journal of Medicinal Chemistry|June 14, 2021
Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse AgonistXishan Wu, Hui Shen, Yan Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Daraxonrasib (RMC-6236) is an effective targeted therapy for <i>RAS</i> -mutant neuroblastomaRonald D Hill, Krista M Dalton, Richard Kurupi, et al.
BMC Public Health|September 5, 2018
Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional studyShishen Wang, Yuhui Tao, Yuchun Tao, et al.
Research Square|June 17, 2024
Targeting of SUMOylation leads to cBAF complex stabilization and disruption of the SS18::SSX transcriptome in Synovial SarcomaKonstantinos V Floros, Carter K Fairchild, Jinxiu Li, et al.
Pageof 4